Wainer Andrea F's Form 4 filing
Abbott Laboratories (ABT) · filed May 3, 2023
- Accession no.
- 0001415889-23-007254
- Filed
- May 3, 2023
- Trade date
- May 2, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $909.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wainer Andrea FCIK 0001778070 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | Common shares without par value | MOption exerciseAcquired | +8,226 | $47.00 | +$386,622 | 78,653 | Direct | |
| May 2, 2023 | Common shares without par value | SSaleDisposed | −8,226 | $110.56 | −$909,466.56 | 70,427 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | Common Shares | MOption exerciseDisposed | −8,226 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.